Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Hyaluronate and Meibomian Gland Treatment in MGD Dry Eye After Phacovitrectomy
NCT05771194Phase 4Completed
- Sponsor
- Tianjin Medical University Eye Hospital
- Start
- Feb 2021
- Primary completion
- Mar 2022
- Modality
- Hydrogel Systems
- Countries
- 1
01
Overview
A Phase 4 trial of sodium hyaluronate anti-adhesion barrier gel in dry eye syndrome (DED), meibomian gland dysfunction (MGD), sponsored by Tianjin Medical University Eye Hospital. Started Feb 2021; status: completed.
02
Drugs
sodium hyaluronate anti-adhesion barrier gel
03
Conditions
dry eye syndrome (DED)meibomian gland dysfunction (MGD)
Beyond the preview
Go deeper on NCT05771194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05771194.